| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |